Portside Wealth Group, LLC Bristol Myers Squibb CO Transaction History
Portside Wealth Group, LLC
- $524 Billion
- Q2 2024
A detailed history of Portside Wealth Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Portside Wealth Group, LLC holds 13,581 shares of BMY stock, worth $667,234. This represents 0.11% of its overall portfolio holdings.
Number of Shares
13,581
Previous 16,315
16.76%
Holding current value
$667,234
Previous $885 Million
36.25%
% of portfolio
0.11%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.17 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.79 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.49 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.67 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.9 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...